Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine

Clinical trial NCT00849069 · TERMINATED

Trial details

NCT number: NCT00849069
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Haemophilus Influenzae Streptococcus Pneumoniae

Start date: 2009-03-12
Primary completion: 2009-04-07
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.